Genes (Jan 2020)

Contribution of Known Genetic Risk Variants to Dyslipidemias and Type 2 Diabetes in Mexico: A Population-Based Nationwide Study

  • Alicia Huerta-Chagoya,
  • Hortensia Moreno-Macías,
  • Magdalena Sevilla-González,
  • Rosario Rodríguez-Guillén,
  • María L. Ordóñez-Sánchez,
  • Donají Gómez-Velasco,
  • Liliana Muñóz-Hernández,
  • Yayoi Segura-Kato,
  • Olimpia Arellano-Campos,
  • Ivette Cruz-Bautista,
  • Carlos A. Aguilar-Salinas,
  • Teresa Tusié-Luna

DOI
https://doi.org/10.3390/genes11010114
Journal volume & issue
Vol. 11, no. 1
p. 114

Abstract

Read online

Dyslipidemias are common risk factors for the development of chronic disorders including type 2 diabetes (T2D). Over 100 associated loci have been identified but few reports have evaluated the population attributable fraction captured by them in population-based nationwide surveys. Therefore, we determined the population contribution of a set of known genetic risk variants to the development of dyslipidemias and T2D in Mexico. This study included 1665 participants from a Mexican National Health Survey carried out in the year 2000. It is a probabilistic complex sample survey of households, which comprises representative data at a national level. 103 previously reported SNPs associated with different dyslipidemias or T2D were genotyped and used to compute polygenic risk scores. We found that the previously known variants associated with dyslipidemias explain at most 7% of the total risk variance of lipid levels. In contrast, the known genetic risk component for T2D explained a negligible amount of variance (0.1%). Notably, variants derived from the Native-American ancestry have the strongest effect and contribute with a high proportion of the variance. These results support the need for additional studies aimed to identify specific genetic risk variants for Mexican population.

Keywords